Post

New research · Ophthalmology
American journal of ophthalmology · 2d
Cohort studyAmerican journal of ophthalmology · 2026

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

Akshara R Legala, Takashi Nishida, Ashley Liang … Jolene C Rudell
Read paper
OphthalmologyCohort study

Menopausal hormone therapy linked to higher risk of strabismus surgery.

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

Akshara R Legala … Jolene C Rudell
American journal of ophthalmology · 2026
Purpose

To evaluate the association between menopausal hormone therapy (menopausal hormone therapy) and strabismus outcomes in menopausal women.

Methods

Female patients in Epic Cosmos with a first menopause diagnosis between ages 44 and 60 years from January 1, 2010, to October 31, 2025 were included.

Results

hormone therapy users had higher odds of needing eye-alignment surgery

HR by subgroup · 95% CI
null = 1
hazards of strabismus diagnosis
1.11
strabismus surgery
1.76
More results

Among 2,154,255 menopausal patients, 197,576 (9.2%) received menopausal hormone therapy and 1,956,679 (90.8%) did not.

Mean age at menopause diagnosis was 54.9 (4.1) years, and 67.3% identified as White.

“
Conclusion

Menopausal hormone therapy was associated with increased risk of strabismus diagnosis and surgery in menopausal women, suggesting a potential relationship between menopausal hormone therapy and ocular alignment outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment